Fundraising Fox

RiverVest Venture Partners2017 Investments

2 investments dated 2017 · listed companies and verified rows first · show all

Tryton MedicalJan 2017SEC filingmedium confidence

Durham, US

AARON V. KAPLAN(Director)SHAWN MCCARTHY(Director)Alejandro Sanchez(Director)Shawn P. McCarthy(Executive Officer, Director)Brett Farabaugh(Executive Officer)Aaron V. Kaplan(Director)

Board seatJay W. Schmelter· per SEC Form D · $8M raise · filed Feb 2017

Allakos Incallakos.comNov 2017

Portfolio company that completed a successful 2018 biotech IPO, resulting in a 9x return for RiverVest.

BiotechSan Carlos, US

Nenad Tomasevic(Executive Officer)Christopher Bebbington(Executive Officer, Director)Alejandro Dorenbaum(Executive Officer)

BoardFarah Champsi(Director)inJohn McKearn(Director)inPeter Moldt(Director)

Co-investorsAlta PartnersNew Enterprise Associates (NEA)Samsara BioCapitalRoche Venture Fund

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.